Menin-MLL
Menin-MLL interaction is a drug target for leukemia treatment. Menin is a multiple endocrine neoplasia (MEN1) products which interacts with MLL (mixed lineage leukemia) in a histone methyltransferase complex.
Products for Menin-MLL
- Cat.No. 상품명 정보
-
GC11837
MI-136
MI-136은 IC50이 31nM이고 Kd가 23.6nM인 메닌-MLL 단백질-단백질 상호작용(PPI)의 억제제입니다. MI-136은 AR 신호 전달을 차단하는 것으로 나타났으며 거세 저항성 종양에 대한 연구 가능성이 있습니다.
-
GC11418
MI-2
Menin-MLL inhibitor 2;Thieno[2,3-d]pyrimidine, 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-propyl-
An inhibitor of menin-MLL fusion protein interactions -
GC10388
MI-2 (hydrochloride)
menin-MLL interaction inhibitor
-
GC12199
MI-3
Menin-MLL inhibitor 3;Thieno[2,3-d]pyrimidine, 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl)-
An inhibitor of menin-MLL fusion protein interactions -
GC12173
MI-nc (hydrochloride)
weak inhibitor of menin-MLL interaction